Literature DB >> 30693052

A case of thrombolytic therapy with recombinant tissue plasminogen activator for mechanical valve thrombosis at 9 weeks of pregnancy in a Japanese woman.

Toshinori Komatsu1, Hirohiko Motoki1, Kazuhiro Kimura1, Tatsuya Saigusa1, Soichiro Ebisawa1, Yusuke Yokokawa2, Hirofumi Ando2, Takashi Ichino3, Koichiro Kuwahara1.   

Abstract

A 29-year-old woman was admitted to our hospital due to diagnosis of pregnancy at 5 weeks and a day. She underwent valve replacement with mechanical heart valve (MHV: SJM valve) for congenital mitral valve regurgitation, when 11 years old. Warfarin 4 mg was used for anticoagulation. After admission, warfarin was replaced by unfractionated heparin (UFH). She developed exertional dyspnea at 8 weeks of pregnancy. Echocardiogram and fluoroscopy showed an immobile leaflet in the closed position. She was diagnosed with mechanical valve thrombosis. Cardiac surgery or thrombolytic therapy (TT) were treatment options. TT is not established, but is reported to be safer than cardiac surgery. Recently, low-dose, slow infusion of recombinant tissue plasminogen activator (rt-PA) therapy showed acceptable results. About 2.5 h after an intravenous injection of rt-PA, diastolic rumble improved to the normal range of leaflet. Thereafter, warfarin was restarted and there was no recurrence of symptoms and no abortion. She was readmitted for the scheduled Caesarean section (CS) at 32 weeks of pregnancy, and warfarin was replaced with UFH. At 34 weeks of pregnancy, a baby was delivered by CS. She suffered hemostasis after surgery under the anticoagulation. Postoperative day 31, both mother and a child were healthy and left the hospital. <Learning objective: The coagulation status is activated and the fibrinolytic activity is reduced during pregnancy. Prosthetic valve thrombosis during pregnancy is known as a life-threatening event for mother and fetus. The treatment strategy for this complication is not well established. Low-dose, slow infusion of recombinant tissue plasminogen activator (rt-PA) therapy showed acceptable results. This case report shows that rt-PA therapy for the prosthetic valve thrombosis in a Japanese pregnancy woman could be an alternative treatment strategy to surgery.>.

Entities:  

Keywords:  Mechanical valve thrombosis; Pregnancy; Recombinant tissue plasminogen activator

Year:  2018        PMID: 30693052      PMCID: PMC6342610          DOI: 10.1016/j.jccase.2018.08.006

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  8 in total

1.  Guidelines for Indication and Management of Pregnancy and Delivery in Women with Heart Disease (JCS 2010): digest version.

Authors: 
Journal:  Circ J       Date:  2011-12-17       Impact factor: 2.993

2.  Thoracic and cardiovascular surgery in Japan during 2011: Annual report by The Japanese Association for Thoracic Surgery.

Authors:  Jun Amano; Hiroyuki Kuwano; Hiroyasu Yokomise
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-10

Review 3.  Management of anticoagulation before and after elective surgery.

Authors:  C Kearon; J Hirsh
Journal:  N Engl J Med       Date:  1997-05-22       Impact factor: 91.245

4.  Pregnancy in Women With a Mechanical Heart Valve: Data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC).

Authors:  Iris M van Hagen; Jolien W Roos-Hesselink; Titia P E Ruys; Waltraut M Merz; Sorel Goland; Harald Gabriel; Malgorzata Lelonek; Olga Trojnarska; Wael Abdulrahman Al Mahmeed; Hajnalka Olga Balint; Zeinab Ashour; Helmut Baumgartner; Eric Boersma; Mark R Johnson; Roger Hall
Journal:  Circulation       Date:  2015-06-22       Impact factor: 29.690

Review 5.  [Pregnancy-Related Venous Thromboembolism].

Authors:  Yuki Kamimoto; Hideo Wada
Journal:  Rinsho Byori       Date:  2015-12

6.  Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves.

Authors:  N Vitale; M De Feo; L S De Santo; A Pollice; N Tedesco; M Cotrufo
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

7.  [Anticoagulant therapy in a pregnant patient with prosthetic mitral valve-emergency for caesarian section and postoperative bleeding].

Authors:  Tetsuhito Masubuchi; Kenji Yoshitani; Takuma Maeda; Makiko Takada; Yoshihiko Ohnishi
Journal:  Masui       Date:  2011-06

8.  Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator.

Authors:  Mehmet Özkan; Beytullah Çakal; Süleyman Karakoyun; Ozan Mustafa Gürsoy; Cihan Çevik; Macit Kalçık; Ali Emrah Oğuz; Sabahattin Gündüz; Mehmet Ali Astarcioglu; Ahmet Çağrı Aykan; Zübeyde Bayram; Murat Biteker; Evren Kaynak; Gökhan Kahveci; Nilüfer Ekşi Duran; Mustafa Yıldız
Journal:  Circulation       Date:  2013-06-28       Impact factor: 29.690

  8 in total
  2 in total

1.  Author's reply to "Anticoagulation strategy and management of patients with mechanical prosthetic heart valves during pregnancy".

Authors:  Toshinori Komatsu; Hirohiko Motoki; Koichiro Kuwahara
Journal:  J Cardiol Cases       Date:  2019-04-09

2.  Anticoagulation strategy and management of patients with mechanical prosthetic heart valves during pregnancy.

Authors:  Semih Kalkan; Ahmet Güner; Macit Kalçık; Emrah Bayam; Mehmet Özkan
Journal:  J Cardiol Cases       Date:  2019-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.